A survey study of self‐reported comorbidities among adults with vitiligo in the United States

Author:

Ezzedine Khaled1ORCID,Anastassopoulos Kathryn P.2,Gandhi Kavita3,Daniel Shoshana R.2,Yamaguchi Yuji4,Sikirica Vanja3,Pandya Amit G.56

Affiliation:

1. Department of Dermatology Hôpital Henri Mondor Créteil France

2. Market Access Consulting Labcorp Drug Development Gaithersburg Maryland USA

3. Patient & Health Impact, Pfizer Collegeville Pennsylvania USA

4. Inflammation & Immunology Research Unit, Pfizer Collegeville Pennsylvania USA

5. Department of Dermatology Palo Alto Foundation Medical Group Sunnyvale California USA

6. Department of Dermatology University of Texas Southwestern Medical Center Dallas Texas USA

Abstract

AbstractBackgroundVitiligo is an autoimmune disorder in which the immune system targets melanocytes, manifesting in patches of lost skin pigmentation.ObjectivesTo characterize the occurrence of autoimmune/autoinflammatory and/or nonautoimmune comorbid conditions in patients with vitiligo.MethodsAdults representative of the 2017 US Census population were recruited for an online, cross‐sectional survey. Based on responses to vitiligo screening questions, participants were categorized into one of three groups: diagnosed vitiligo, undiagnosed vitiligo and no vitiligo. Participants reported clinical‐diagnosed conditions from prespecified lists of 13 autoimmune/autoinflammatory conditions and 21 nonautoimmune conditions.ResultsA total of 40,888 adults participated in the online survey; 315 (0.8%) were categorized as diagnosed vitiligo, 249 (0.6%) as undiagnosed vitiligo and 40,325 (98.6%) as no vitiligo. The percentage of participants with at least one autoimmune/autoinflammatory comorbidity was 2.65 times greater in the diagnosed vitiligo group than in the no vitiligo group. Psoriasis, rheumatoid arthritis and multiple sclerosis had the greatest difference in the percentage of participants between the diagnosed vitiligo and no vitiligo groups. The percentage of participants with nonautoimmune comorbidities was higher in the diagnosed vitiligo group than in the no vitiligo group. Vision changes, arthritis, back pain, anxiety, depression and sudden hearing loss had the greatest difference in the percentage of participants between the diagnosed vitiligo group and the no vitiligo group.ConclusionsThis large survey found that both autoimmune/autoinflammatory and nonautoimmune conditions were more common among adults with vitiligo. The greater percentage of autoimmune/autoinflammatory conditions in participants with vitiligo suggests that screening for such comorbidities may be beneficial and may indicate important opportunities for early intervention.

Funder

Pfizer

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3